 <h1>Atacand HCT Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>candesartan / hydrochlorothiazide</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about candesartan / hydrochlorothiazide. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Atacand HCT.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to candesartan / hydrochlorothiazide: oral tablet</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet)</p><p>When pregnancy is detected, discontinue candesartan cilexetil/hydrochlorothiazide as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, candesartan / hydrochlorothiazide may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking candesartan / hydrochlorothiazide:</p><p>
<i>Less common</i>
</p><ul>
<li>Cough</li>
<li>dizziness</li>
<li>dryness of the mouth</li>
<li>fever</li>
<li>increased thirst</li>
<li>irregular heartbeat</li>
<li>lightheadedness</li>
<li>muscle cramps</li>
<li>nausea</li>
<li>sore throat</li>
<li>unusual tiredness</li>
<li>vomiting</li>
<li>weak pulse</li>
<li>weakness</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Arm pain</li>
<li>chest pain or tightness</li>
<li>fast heartbeat</li>
<li>large, hive like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs</li>
<li>trouble breathing</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Black, tarry stools</li>
<li>chills</li>
<li>confusion</li>
<li>lower back or side pain</li>
<li>nervousness</li>
<li>numbness or tingling in the hands, feet, or lips</li>
<li>painful or difficult urination</li>
<li>pale skin</li>
<li>persistent non-healing sore</li>
<li>pink growth</li>
<li>reddish patch or irritated area</li>
<li>shiny bump</li>
<li>sores, ulcers, or white spots in the mouth or on the lips</li>
<li>stomach pain</li>
<li>swelling of the face, ankles, or hands</li>
<li>unusual bleeding or bruising</li>
<li>weakness or heaviness of the legs</li>
<li>white, yellow or waxy scar-like area</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of candesartan / hydrochlorothiazide may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Back pain</li>
<li>diarrhea</li>
<li>headache</li>
<li>joint pain</li>
<li>loss of appetite</li>
<li>muscle aches and pains</li>
<li>runny nose</li>
<li>sneezing</li>
<li>sweating</li>
<li>trouble sleeping</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Blistering, peeling, loosening of skin</li>
<li>decreased interest in sexual intercourse</li>
<li>hair loss, thinning of the hair</li>
<li>hives or welts, itching, skin rash</li>
<li>inability to have or keep an erection</li>
<li>increased sensitivity of the skin to sunlight</li>
<li>loss in sexual ability, desire, drive, or performance</li>
<li>redness of the skin</li>
<li>redness or other discoloration of the skin</li>
<li>red irritated eyes</li>
<li>red skin lesions, often with a purple center</li>
<li>severe sunburn</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to candesartan / hydrochlorothiazide: oral tablet</i></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Upper respiratory tract infection, respiratory infection, bronchitis, pharyngitis, sinusitis, nasopharyngitis, cough</p>
<p></p>
<p>Candesartan:</p>
<p><b>Frequency not reported</b>: Cough, rhinitis</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Pneumonitis, pulmonary edema<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Hypokalemia, dyslipidemia</p>
<p><b>Uncommon</b> (0.1% to 1%): Hyperkalemia</p>
<p></p>
<p>Candesartan:</p>
<p><b>Very rare</b> (less than 0.01%): Hyponatremia, hyperkalemia</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Anorexia, loss of appetite, hyperglycemia, hyperuricemia, hyponatremia, hypokalemia, cholesterol increased, triglycerides increased<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Abdominal pain, nausea</p>
<p><b>Uncommon</b> (0.1% to 1%): Vomiting</p>
<p></p>
<p>Candesartan:</p>
<p><b>Frequency not reported</b>: Diarrhea</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Gastric irritation, diarrhea, constipation</p>
<p><b>Postmarketing reports</b>: Sialadenitis, cramping<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Influenza-like symptoms, inflicted injury</p>
<p><b>Frequency not reported</b>: Fatigue</p>
<p></p>
<p>Candesartan:</p>
<p><b>Frequency not reported</b>: Peripheral edema</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Fever, weakness, vertigo<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, headache</p>
<p></p>
<p>Candesartan:</p>
<p><b>Postmarketing reports</b>: Somnolence</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Lightheadedness, paresthesia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Tachycardia</p>
<p><b>Uncommon</b> (0.1% to 1%): Atrioventricular block</p>
<p></p>
<p>Candesartan:</p>
<p><b>Postmarketing reports</b>: Palpitations</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Vasculitis, postural hypotension, cardiac arrhythmias<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain</p>
<p><b>Postmarketing reports</b>: Myalgia</p>
<p></p>
<p>Candesartan:</p>
<p><b>Postmarketing reports</b>: Rhabdomyolysis</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Muscle spasm<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Glycosuria</p>
<p><b>Postmarketing reports</b>: Impotence<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Candesartan:</p>
<p><b>Very rare</b> (less than 0.01%): Angioedema, urticaria, pruritus, rash</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Photosensitivity reactions, rash, cutaneous lupus erythematosus-like reactions, reactivation of cutaneous lupus erythematosus, urticaria, cutaneous vasculitis, toxic epidermal necrolysis</p>
<p><b>Postmarketing reports</b>: Purpura, erythema multiforme, Stevens-Johnson syndrome, exfoliative dermatitis, alopecia<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Candesartan:</p>
<p><b>Very rare</b> (less than 0.01%): Leucopenia, neutropenia, agranulocytosis</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Leucopenia, neutropenia, agranulocytosis, thrombocytopenia, aplastic anemia, hemolytic anemia, bone marrow depression<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Candesartan:</p>
<p><b>Very rare</b> (less than 0.01%): Liver enzymes increased, abnormal hepatic function, hepatitis</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Intrahepatic cholestatic jaundice, pancreatitis<sup>[Ref]</sup></p><h3>Renal</h3><p>Candesartan:</p>
<p><b>Very rare</b> (less than 0.01%): Renal impairment, renal failure</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: BUN increased, serum creatinine increased, renal dysfunction, interstitial nephritis<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>Candesartan:</p>
<p><b>Postmarketing reports</b>: Agitation, anxiety, depression, insomnia, nervousness, sleep disorder, nightmare</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Restlessness, sleep disturbances, depression<sup>[Ref]</sup></p><h3>Ocular</h3><p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Transient blurred vision, acute myopia, acute angle-closure glaucoma, xanthopsia<sup>[Ref]</sup></p><h3>Immunologic</h3><p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Anaphylactic reactions<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Atacand HCT (candesartan-hydrochlorothiazide)" AstraZeneca Pharmaceuticals, Wilmington, DE. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Atacand HCT (candesartan / hydrochlorothiazide)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Generic Availability</li>
<li>Drug class: angiotensin II inhibitors with thiazides</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Atacand HCT &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Other Formulations</h3>
<ul class="more-resources-list more-resources-list-formulations">
<li>Atacand</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>High Blood Pressure</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to candesartan / hydrochlorothiazide: oral tablet</i></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Upper respiratory tract infection, respiratory infection, bronchitis, pharyngitis, sinusitis, nasopharyngitis, cough</p><p></p><p>Candesartan:</p><p><b>Frequency not reported</b>: Cough, rhinitis</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Pneumonitis, pulmonary edema<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Hypokalemia, dyslipidemia</p><p><b>Uncommon</b> (0.1% to 1%): Hyperkalemia</p><p></p><p>Candesartan:</p><p><b>Very rare</b> (less than 0.01%): Hyponatremia, hyperkalemia</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Anorexia, loss of appetite, hyperglycemia, hyperuricemia, hyponatremia, hypokalemia, cholesterol increased, triglycerides increased<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Abdominal pain, nausea</p><p><b>Uncommon</b> (0.1% to 1%): Vomiting</p><p></p><p>Candesartan:</p><p><b>Frequency not reported</b>: Diarrhea</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Gastric irritation, diarrhea, constipation</p><p><b>Postmarketing reports</b>: Sialadenitis, cramping<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Influenza-like symptoms, inflicted injury</p><p><b>Frequency not reported</b>: Fatigue</p><p></p><p>Candesartan:</p><p><b>Frequency not reported</b>: Peripheral edema</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Fever, weakness, vertigo<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, headache</p><p></p><p>Candesartan:</p><p><b>Postmarketing reports</b>: Somnolence</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Lightheadedness, paresthesia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Tachycardia</p><p><b>Uncommon</b> (0.1% to 1%): Atrioventricular block</p><p></p><p>Candesartan:</p><p><b>Postmarketing reports</b>: Palpitations</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Vasculitis, postural hypotension, cardiac arrhythmias<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain</p><p><b>Postmarketing reports</b>: Myalgia</p><p></p><p>Candesartan:</p><p><b>Postmarketing reports</b>: Rhabdomyolysis</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Muscle spasm<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Glycosuria</p><p><b>Postmarketing reports</b>: Impotence<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Candesartan:</p><p><b>Very rare</b> (less than 0.01%): Angioedema, urticaria, pruritus, rash</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Photosensitivity reactions, rash, cutaneous lupus erythematosus-like reactions, reactivation of cutaneous lupus erythematosus, urticaria, cutaneous vasculitis, toxic epidermal necrolysis</p><p><b>Postmarketing reports</b>: Purpura, erythema multiforme, Stevens-Johnson syndrome, exfoliative dermatitis, alopecia<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Candesartan:</p><p><b>Very rare</b> (less than 0.01%): Leucopenia, neutropenia, agranulocytosis</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Leucopenia, neutropenia, agranulocytosis, thrombocytopenia, aplastic anemia, hemolytic anemia, bone marrow depression<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Candesartan:</p><p><b>Very rare</b> (less than 0.01%): Liver enzymes increased, abnormal hepatic function, hepatitis</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Intrahepatic cholestatic jaundice, pancreatitis<sup>[Ref]</sup></p><h3>Renal</h3><p>Candesartan:</p><p><b>Very rare</b> (less than 0.01%): Renal impairment, renal failure</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: BUN increased, serum creatinine increased, renal dysfunction, interstitial nephritis<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>Candesartan:</p><p><b>Postmarketing reports</b>: Agitation, anxiety, depression, insomnia, nervousness, sleep disorder, nightmare</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Restlessness, sleep disturbances, depression<sup>[Ref]</sup></p><h3>Ocular</h3><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Transient blurred vision, acute myopia, acute angle-closure glaucoma, xanthopsia<sup>[Ref]</sup></p><h3>Immunologic</h3><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Anaphylactic reactions<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Atacand HCT (candesartan-hydrochlorothiazide)" AstraZeneca Pharmaceuticals, Wilmington, DE. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2>More about Atacand HCT (candesartan / hydrochlorothiazide)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Generic Availability</li>
<li>Drug class: angiotensin II inhibitors with thiazides</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Atacand HCT &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Other Formulations</h3><ul class="more-resources-list more-resources-list-formulations">
<li>Atacand</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>High Blood Pressure</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>